BreathLink rapid point-of-care breath test for breast cancer: Pilot trial data

A Dutch and U.S. pilot trial in 244 women who had a screening mammogram or breast biopsy showed that Menssana's BreathLink rapid point-of-care breath test for breast cancer had a 99.9% negative predic...